Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28382164 | 0.86 | TSHR (0.39) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL1547302 | 0.86 | CA1 (0.52) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL4961769 | 0.83 | ALOX5 (0.42) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL14341464 | 0.82 | ALOX5 (0.49) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL696242 | 0.81 | TP53 (0.43) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL16954859 | 0.81 | ALDH1A1 (0.45) | KDM4EALDH1A1LMNAMAPTCYP1A2 | |
| SCHEMBL2380969 | 0.81 | CA1 (0.42) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL2424037 | 0.81 | TAAR1 (0.42) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL695730 | 0.81 | CA1 (0.42) | KDM4ECA1CA2CA7CA9 | |
| SCHEMBL14999450 | 0.80 | ACHE (0.38) | KDM4ECA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2960299-A1 | POLYMER COMPOSITION AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-12-30 | — | — | EP | claimed |
| EP-1894976-B1 | POLYMER COMPOSITION AND POLYMER LIGHT-EMITTING DEVICE USING SAME | SUMITOMO CHEMICAL CO (JP) | 2015-09-30 | — | — | EP | claimed |
| US-9045613-B2 | Polymer composition and polymer light-emitting device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-06-02 | — | — | US | claimed |
| JP-4729040-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| EP-1761574-A1 | POLYMERIZATION PROCESS USING HYDROFLUOROCARBONS | ExxonMobil Chemical Patents Inc. (US) | 2007-03-14 | — | — | EP | claimed |
| WO-2006011868-A1 | POLYMERIZATION PROCESSES USING HYDROFLUOROCARBONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-02-02 | — | — | WO | claimed |
| EP-3626802-B1 | METHOD FOR PRODUCING LIQUID COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2024-12-25 | — | — | EP | disclosed |
| US-11787813-B2 | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors | KSQ Therapeutics, Inc. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230203046-A1 | SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | KSQ Therapeutics, Inc. | 2023-06-29 | — | — | US | disclosed |
| US-20230041518-A1 | QUINOLINE DERIVATIVES | GILEAD SCIENCES, INC. | 2023-02-09 | — | — | US | disclosed |
| EP-3898712-A1 | PROCESS FOR THE PRODUCTION OF ISOOLEFIN POLYMERS USING A TERTIARY ETHER | Arlanxeo Singapore Pte. Ltd. (SG) | 2021-10-27 | — | — | EP | disclosed |
| US-11116760-B2 | Quinoline derivatives | GILEAD SCIENCES, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| US-11046886-B2 | Method for producing liquid composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-29 | — | — | US | disclosed |
| US-7504417-B2 | Substituted benzene derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2009-03-17 | — | — | US | disclosed |
| EP-1894976-A1 | POLYMER COMPOSITION AND POLYMER LIGHT-EMITTING DEVICE USING SAME | Sumitomo Chemical Company, Limited (JP) | 2008-03-05 | — | — | EP | disclosed |
| EP-1572763-A4 | POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2006-07-26 | — | — | EP | disclosed |
| EP-1572763-A2 | POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS | ExxonMobil Chemical Patents Inc. (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004058825-A2 | POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-0910573-A1 | NEW AMINO ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | Astra Aktiebolag (SE) | 1999-04-28 | — | — | EP | disclosed |
| WO-1997046577-A1 | NEW AMINO ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRA AKTIEBOLAG (SE) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787813-B2 | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors | USP1, UPP1, USP2 | KDM4E 825/4885CA1 3205/4885CA2 4388/4885 |
| US-20230041518-A1 | QUINOLINE DERIVATIVES | CFTR, NQO1, IRF3 | KDM4E 2522/4885CA1 4380/4885CA2 2460/4885 |
| US-20230203046-A1 | SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | USP1, UPP1, USP2 | KDM4E 825/4885CA1 3205/4885CA2 4388/4885 |
| US-11116760-B2 | Quinoline derivatives | CFTR, NQO1, IRF3 | KDM4E 2522/4885CA1 4380/4885CA2 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.